Patent US2160371A successfully refreshed from Google Patents.

Patent US6709425B2 successfully refreshed from Google Patents.

US6709425B2 Expired / Lapsed US ⏱️ 0.0 years remaining

Vascular inducing implants

Assignee: CR Bard Inc

•

Filing: 2001-01-31

•

Granted: 2004-03-23

•

Expires: 2021-01-31

📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Implants and associated delivery systems for promoting angiogenesis in ischemic tissue are provided. The implants may be delivered percutaneously, thoracically or surgically and are particularly well suited for implantation into the myocardium of the heart. The implants are configured to have a first configuration having a low profile and an expanded, second configuration having a large profile. The implants are delivered to the ischemic tissue location in the first configuration, implanted then expanded to the second configuration. The expanded implants maintain a stress on the surrounding tissue, irritating and slightly injuring the tissue to provoke an injury response that results in angiogenesis. The flow of blood from the surrounding tissue into the implant and pooling of the blood in and around the implant leads to thrombosis and fibrin growth. This healing process leads to angiogenesis in the tissue surrounding the implant. Additionally, the implants may contain an angiogenic substance or a thrombus of blood, preloaded or injected after implantation to aid in initiating angiogenesis.

Inventors

👤 Richard A. Gambale
👤 Stephen J. Forcucci
👤 Michael F. Weiser
👤 Richard T. Choh
👤 Sean Forde

Bibliographic Details

Application Number —

Jurisdiction US

Data Source google_patents

Last Synchronized 2026-10-24 10:24

CPC Classifications

A; A61; A61F; A61F2/00; A61F2/82; A61F2/94; A61B; A61B17/00; A61B17/00234; A61F2/02; A61F2/04; A61F2/06; A61F2/24; A61F2/2493; A61B2017/00238; A61B2017/00243; A61F2220/00; A61F2220/0008; A61F2220/0016; A61F2220/0025; A61F2220/005; A61F2220/0058; A61F2230/00; A61F2230/0063; A61F2230/0073; A61F2230/0076; A61F2230/0091; A61F2250/00; A61F2250/0058; A61F2250/0067

Claims Analysis

Total Claims: 8

Claim 1

Independent Claim 60 words

A method of promoting angiogenesis in ischemic tissue comprising the steps of: providing an implant, associating an angiogenic substance with the implant, accessing the ischemic tissue, inserting the implant into the tissue, orienting the implant in the tissue to place the tissue in stress by expanding the implant from a low profile first configuration to a large profile second configuration.

Claim 2

Independent Claim 60 words

Claim 3

Dependent Claim 26 words

A method of promoting angiogenesis as defined in claim 1 comprising the further step of associating a angiogenic substance with the device after it is implanted.

Claim 4

Dependent Claim 26 words

A method of promoting angiogenesis as defined in claim 1 wherein the implant comprises a body having an interior containing an angiogenic substance to promote angiogenesis.

Claim 5

Dependent Claim 33 words

A method of promoting angiogenesis in ischemic tissue as defined in claim 1 further comprising: irritating the tissue sufficiently to cause an injury response in the tissue that includes thrombosis and initiates angiogenesis.

Claim 6

Dependent Claim 25 words

A method of promoting angiogenesis as defined in claim 4 wherein the tissue irritation is caused by the presence of a implant in the tissue.

Claim 7

Dependent Claim 18 words

A method as defined in claim 5 wherein the implants are implanted entirely and only within the myocardium.

Claim 8

Dependent Claim 16 words

A method of promoting angiogenesis as defined in claim 5 wherein the tissue is myocardial tissue.

References Cited (Backward Citations)

FR1514319A Cited

US3995617A Cited

US3991750A Cited

US4641653A Cited

US4307722A Cited

US4655771A Cited

US4655771B1 Cited

US4546499A Cited

US4562597A Cited

US4503569A Cited

US4774949A Cited

US4582181A Cited

US4904264A Cited

RU2026640C1 Cited

US5114414A Cited

US4580568A Cited

US4658817A Cited

US4733665C2 Cited

US4733665A Cited

US4733665B1 Cited

US4681110A Cited

US4665918A Cited

US4649922A Cited

US4768507A Cited

US4861330A Cited

US4813925A Cited

US5098374A Cited

US4920980A Cited

US5487739A Cited

US5266073A Cited

US4889137A Cited

US4950227A Cited

US4917666A Cited

US4995857A Cited

US5047028A Cited

US5056517A Cited

US4997431A Cited

US5042486A Cited

US5049138A Cited

US5158548A Cited

US5087243A Cited

US5040543A Cited

US5180366A Cited

US5653756A Cited

US5741330A Cited

US5167514A Cited

EP0490459B1 Cited

US5380316A Cited

US5389096A Cited

US5312456A Cited

US5569272A Cited

US5676850A Cited

US5366493A Cited

EP0515867B1 Cited

US5190058A Cited

US5324325A Cited

US5551954A Cited

US5256146A Cited

US5372600A Cited

US5176626A Cited

US5423885A Cited

US5593434A Cited

US5290295A Cited

US5429144A Cited

US5409019A Cited

US5287861A Cited

US5452733A Cited

US5562922A Cited

US5464650A Cited

US5425757A Cited

US5409004A Cited

US5458615A Cited

US5480422A Cited

US5391199A Cited

US5562619A Cited

US5464404A Cited

RU2063179C1 Cited

US5735897A Cited

US5602301A Cited

US5476505A Cited

US5466242A Cited

US5593412A Cited

US5453090A Cited

US5441516A Cited

US5879383A Cited

US5762600A Cited

FR2725615B1 Cited

US5830502A Cited

EP0714640A1 Cited

EP0717969A3 Cited

US5514176A Cited

US5551427A Cited

US5643308A Cited

US5792453A Cited

US5614206A Cited

EP0732089A2 Cited

US5571168A Cited

US5744515A Cited

US5824049A Cited

US5840059A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage	Window Opens	Payment Deadline	Surcharge Period Until	Estimated Fee	Status
3.5 Years (Year 4)	2007-03-23	2007-09-22	2008-03-23	$2000.00	Window Closed / Lapsed
7.5 Years (Year 8)	2011-03-23	2011-09-22	2012-03-23	$3760.00	Window Closed / Lapsed
11.5 Years (Year 12)	2015-03-23	2015-09-22	2016-03-23	$7700.00	Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag

Select Category

Notes (Optional)